June 7, 2022

In a recent bulletin, Alverno Laboratories issued several updates for healthcare providers. They have transitioned viral load testing to the Alinity m instruments, discontinuing several test codes and introducing new quantitative viral load test codes along with specimen collection guidelines. Additionally, they suspended quantitative reporting for N-desmethyltramadol due to jurisdiction changes, seeking special licensing, and will now only provide qualitative reporting during this period. The reference ranges for Anti-Streptolysin-O have been updated, especially for patients aged up to 2 years and from 3 years to adult. Furthermore, reporting of cell counts for broncho-alveolar lavage (BAL) specimens will cease, while lead critical values for pediatric lead testing will be updated to ≥ 3.5 ug/dL for children aged 0 to 15 years, aligning with CDC guidelines. These updates offer crucial information for healthcare providers regarding changes in testing procedures, reporting standards, and reference ranges at Alverno Laboratories.